An Australian company may have stumbled across a cure for high blood pressure and heart disease during a clinical trial for osteoarthritis.
Bendigo, Victoria (PRWEB) April 6, 2009 -- The Elmore Oil Company, a Bendigo based company who manufactures a topical pain relief lotion for arthritis and muscular pain, recently undertook a double blind placebo controlled trial for their flagship product, Elmore Oil.
The trial was headed by Dr. Ruth S. Sy, head Rheumatologist at the Veterans Memorial Hospital in Quezon City and co-ordinated by respected researcher, Dr. Leticia Lucero-Palma. In what could be a major breakthrough in medical science, all the patients in the trial have recorded reduced uric acid levels after being in the program for as little as 4 weeks.
The trial was set up to study the effects of Elmore Oil against a placebo, on patients aged between 45 and 90 years of age, who have been clinically diagnosed with osteoarthritis. The patients all recorded their pain levels in a detailed diary but they have also been blood tested prior to the trial and weekly thereafter.
Dr. Palma noticed a marked drop in uric acids levels in all patients, up to 50% in some cases, which has led to an excited optimism that the company may have stumbled on a potential cure for high blood pressure and heart disease, as well as debilitating diseases like gout. While it is too early to make assumptions the company is prepared to fund more research into the potential cure.
A story on the effects of the product for arthritis, as well as the uric acid discovery, was recently aired on Australias leading news program, A Current Affair, in the first week of April.
According to an article published in the Journal of the American Medical Association, high uric acid levels can definitely lead to heart disease. Doctors studied nearly 6,000 people over a 20 year period. Approximately 1,50
Copyright©2009 Vocus, Inc.
All rights reserved